Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:00 PM
Ignite Modification Date:
2025-12-24 @ 1:00 PM
NCT ID:
NCT01715961
Eligibility Criteria:
Inclusion Criteria:
* Patients \>= 70 years
* DLBCL, grade IIIB follicular lymphoma or histologically proven transformed low grade lymphoma
* Whatever the IPI score and the performance status
* Treated by Rituximab-CHOP or Rituximab-mini-CHOP
* CT scan imaging performed one month or less before inclusion
* Signed informed consent
Exclusion Criteria:
* No initial CT scan imaging performed more than one month before inclusion
* Positivity for HCV, HBV and HIV
* Anthracycline contra-indication
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
70 Years
Study:
NCT01715961
Study Brief:
Protocol Section:
NCT01715961